Article Details

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy

Retrieved on: 2025-02-06 01:02:55

Tags for this article:

Click the tags to see associated articles and topics

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy. View article details on hiswai:

Summary

The article discusses biotech research focusing on immunology, specifically examining PD-L1 and PD-1 interactions in cancer treatments. Key elements include cell biology techniques, immune system assays, and data analysis from databases in the U.S. and China.

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up